Supply Chain

Managing supplies is a crucial part of moving medical products from the manufacturer to patient’s bedside. Efficient supply chains can reduce healthcare costs and make medical devices more affordable for patients and health systems. This news page includes content on supply shortages, inventory management, and procurement practices.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine
The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.
FDA investigating outbreak of ‘extensively’ antibiotic resistant salmonella linked to supplement
Capsules of moringa tree leaf, branded as Rosabella, are being recalled after seven states report cases of the illness, with three patients saying they took the supplement. The company has issued an emergency recall.
Bayer: Aiding Customer Resilience Amid CT Disruption
U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.
FDA approves medical device for pancreatic cancer therapy—the first new treatment in 30 years
Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.
Baxter cuts 90 jobs from IV solutions site once devastated by Hurricane Helene
The facility near Asheville, North Carolina, was shut down after floodwater from the 2024 hurricane left its production lines inoperable. It took the company roughly five months to resume normal operations—and now it’s seeing a slowdown in demand in wake of the supply chain disruption.

Moderna, FDA reach compromise to accelerate approval of mRNA flu vaccine

The dispute centered around the pharmaceutical company's request for the shot to be approved for those aged 65 and over, a demographic the FDA argued was not properly represented in a 40,000-person clinical study. The company has agreed to perform additional research after the shot goes to market, having appeased regulators with safety data.

Rosabella Moringa FDA recall supplement salmonella

FDA investigating outbreak of ‘extensively’ antibiotic resistant salmonella linked to supplement

Capsules of moringa tree leaf, branded as Rosabella, are being recalled after seven states report cases of the illness, with three patients saying they took the supplement. The company has issued an emergency recall.

Bayer: Aiding Customer Resilience Amid CT Disruption

Sponsored by Bayer

U.S. Radiology departments navigating CT market challenges—supply disruptions and rising demand for contrast and delivery—need reliable partners. Hear Bayer leads explain how Bayer helps provide steady supply and innovations to support CT imaging and patient care.

CT findings linked with pancreatic cancer

FDA approves medical device for pancreatic cancer therapy—the first new treatment in 30 years

Developed by Novocure, the portable Optune Pax system uses tumor treating fields aimed directly at the site of the cancer to disrupt cell reproduction. A Phase 3 clinical trial shows it improves survival by two months on average versus chemotherapy alone.

Helene damage to bridge Baxter North Cove facility in North Carolina.

Baxter cuts 90 jobs from IV solutions site once devastated by Hurricane Helene

The facility near Asheville, North Carolina, was shut down after floodwater from the 2024 hurricane left its production lines inoperable. It took the company roughly five months to resume normal operations—and now it’s seeing a slowdown in demand in wake of the supply chain disruption.

Rich Fabian, Medical Imaging Technology at AdvaMed Imaging chair of board, a medtech industry group made up of medical imaging companies to address higher level trends and public policy concerns, said tariffs are having a major impact for all vendors due to diverse supply chains that cannot be changed overnight. He said the U.S. tariffs and counter tariffs from, various countries will raise costs for U.S. health systems at a time where margins for them are already razor thin. #RSNA

Medical imaging industry group shares tariff concerns

AdvaMed, a medtech industry group made up of medical imaging companies, says tariffs are having a major impact for all vendors.

TrumpRx launches with 40 brand-name medications available, including popular weight-loss drugs

Discounts represent out-of-pocket costs and come in the form of direct-to-consumer sales through manufacturer websites or via a coupon. AstraZeneca, Eli Lilly, EMD Serono, Novo Nordisk and Pfizer have all listed some of their most popular drugs on the TrumpRx.gov portal.

FTC settles lawsuit against Express Scripts in deal that includes TrumpRx support

The Federal Trade Commission was suing the pharmacy benefit manager over allegations it was deliberately inflating the price of insulin. Per the agreement, Express Scripts has agreed to end business practices that involved taking manufacturer rebates on wholesale drug costs without passing them on to patients.